CAR cells and antibodies targeting human B7-H4 expressed on many human cancers including but not limited to breast, ovarian, and renal cancers are described as a new method of cancer treatment. It is proposed that B7-H4 CAR cells are safe and effective in patients and can be used to treat human tumors expressing the B7-H4 surface protein.